Tejaswini Pradhan

Employment

• Centre of Biomedical Research Assistant Professor
  2025 - Present
• Technical University of Munich Post Doc
  2019 - 2025

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (10)

• Mechanistic insights into the aggregation pathway of the patient-derived immunoglobulin light chain variable domain protein FOR005
  Nature Communications 2023 DOI: 10.1038/s41467-023-39280-0
  +Save
• Protease resistance of ex vivo amyloid fibrils implies the proteolytic selection of disease-associated fibril morphologies
  Amyloid 2021 DOI: 10.1080/13506129.2021.1960501
  +Save
• Protease resistance of ex vivo amyloid fibrils implies the proteolytic selection of disease-associated fibril morphologies
  bioRxiv 2021 DOI: 10.1101/2021.07.05.451219
  +Save
• Seeded fibrils of the germline variant of human λ-III immunoglobulin light chain FOR005 have a similar core as patient fibrils with reduced stability
  Journal of Biological Chemistry 2020 DOI: 10.1074/jbc.RA120.016006
  +Save
• Solid state NMR assignments of a human λ-III immunoglobulin light chain amyloid fibril.
  Biomolecular NMR assignments 2020 DOI: 10.1007/s12104-020-09975-2
  +Save
• Amyloidogenic core of a human λ-III immunoglobulin light chain fibril and their germline variants probed by MAS solid state NMR
  bioRxiv 2020 DOI: 10.1101/2020.10.02.323303
  +Save
• Domain Interactions Determine the Amyloidogenicity of Antibody Light Chain Mutants
  Journal of Molecular Biology 2020 DOI: 10.1016/j.jmb.2020.10.005
  +Save
• A single residue switch reveals principles of antibody domain integrity
  Journal of Biological Chemistry 2018 DOI: 10.1074/jbc.RA118.005475
  +Save
• PAMPA permeability, plasma protein binding, blood partition, pharmacokinetics and metabolism of formononetin, a methoxylated isoflavone
  Food and Chemical Toxicology 2011 DOI: 10.1016/j.fct.2011.01.012
  +Save
• Prediction of human absorption of a trioxane antimalarial drug (CDRI 99/411) using an in-house validated in situ single-pass intestinal perfusion model
  Arzneimittel-Forschung/Drug Research 2011 DOI: 10.1055/s-0031-1296240
  +Save